Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.

Mounjaro, also known as tirzepatide, works by regulating the user’s appetite by mimicking a naturally produced hormone called glucagon-like peptide-1 (GLP-1). When we eat, GLP-1 is released and ...

(Reuters) -Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug, ...

Illicit weight loss drugs, Botox, steroids, and erectile dysfunction and anti-anxiety tablets were among a significant police ...

The Medicines and Healthcare products Regulatory Agency and Genomics England have launched a pioneering investigation into whether a person’s genetic makeup may influence their risk of developing ...

LONDON - Weight loss and diabetes injections, once widely praised, are now under scrutiny after reports of severe health ...

GPs have been urged to be vigilant to signs of acute pancreatitis in patients who are taking GLP-1 weight-loss drugs.

The count-down's on for New Zealand chemist sales of weight-loss drug Wegovy. A pharmacist has told our newsroom the ...